Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups.

Primary tissue failure (structural valve deterioration) has been documented as the most prominent complication of porcine bioprostheses. The influence of age on primary tissue failure has received limited consideration. From 1975 to 1986, 1,301 Carpentier-Edwards standard porcine bioprostheses were implanted in 1,183 patients in 1,201 operations. Of the total number of prostheses, 97.7% were implanted prior to 1983. The mean follow-up was 5.6 years and was 97.5% complete. Primary tissue failure was identified in 96 patients (98 operations) at reoperation (95) or autopsy (3). One hundred four (104) prostheses were involved. Thirty-one failed after aortic valve replacement (AVR), 49 after mitral valve replacement (MVR), and 24 after multiple-valve replacement (18 patients). There were 47 male and 49 female patients. The mean age at implantation was 47 years (range, 8 to 72 years). The mean implantation time was 74.0 months. The freedom from primary tissue failure at 10 years is 77.0 +/- 2.9% overall; for AVR, 83.1 +/- 3.7%; for MVR, 72.1 +/- 4.9%; and for multiple-valve replacement, 65.5 +/- 7.8%. The freedom from deterioration for patients less than 20 years of age is significantly less than that for other age groups. The freedom from deterioration increased by decades; the greatest freedom was noted in patients 70 to 80 years old and 80 years old or older. The freedom from deterioration at 10 years for patients less than 30 years of age is 26.8 +/- 17.2%; 30 to 59 years, 77.4 +/- 3.0%; and 60 years and older, 83.1 +/- 4.2%.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  A. Mitha,et al.  Severe calcification of glutaraldehyde-preserved porcine xenografts in children. , 1980, The American journal of cardiology.

[2]  T. Gardner,et al.  Valve replacement in children. A fifteen-year perspective. , 1982, The Journal of thoracic and cardiovascular surgery.

[3]  B. Chaitman,et al.  Five-year evaluation of the Carpentier-Edwards porcine bioprosthesis. , 1984, The Journal of thoracic and cardiovascular surgery.

[4]  G. Poletti,et al.  Porcine cardiac bioprostheses: evaluation of long-term results in 990 patients. , 1985, The Annals of thoracic surgery.

[5]  F. Nistal,et al.  Four- to seven-year follow-up of patients undergoing Carpentier-Edwards porcine heart valve replacement. , 1985, The Thoracic and cardiovascular surgeon.

[6]  W. Jamieson,et al.  Carpentier-Edwards supra-annular porcine bioprosthesis. Clinical experience and implantation characteristics. , 1986, The Journal of thoracic and cardiovascular surgery.

[7]  G. Rábago,et al.  Long-term comparative analysis of the Björk-Shiley and Hancock valves implanted in 1975. , 1985, The Journal of thoracic and cardiovascular surgery.

[8]  L. Cohn,et al.  Early and late risk of aortic valve replacement. A 12 year concomitant comparison of the porcine bioprosthetic and tilting disc prosthetic aortic valves. , 1984, The Journal of thoracic and cardiovascular surgery.

[9]  F. Nistal,et al.  Incidence of primary tissue valve failure with the Ionescu-Shiley pericardial valve. Preliminary results. , 1985, The Journal of thoracic and cardiovascular surgery.

[10]  Jamieson Wr Bioprostheses for cardiac valve replacement. , 1985 .

[11]  F. Nistal,et al.  Primary tissue valve degeneration in glutaraldehyde-preserved porcine bioprostheses: Hancock I versus Carpentier-Edwards at 4- to 7-years' follow-up. , 1986, The Annals of thoracic surgery.

[12]  P J Commerford,et al.  Calcification of glutaraldehyde-preserved porcine xenografts in young patients. , 1981, The Journal of thoracic and cardiovascular surgery.

[13]  M. Antunes,et al.  Performance of glutaraldehyde-preserved porcine bioprosthesis as a mitral valve substitute in a young population group. , 1984, The Annals of thoracic surgery.

[14]  W. Roberts,et al.  Late failure of porcine valve heterografts in children. , 1979, The Journal of thoracic and cardiovascular surgery.

[15]  W. Williams,et al.  Calcification in porcine xenograft valves in children. , 1980, The American journal of cardiology.

[16]  L. Cohn,et al.  Early and late risk of mitral valve replacement. A 12 year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves. , 1985, The Journal of thoracic and cardiovascular surgery.

[17]  J. Moran,et al.  An eight-year experience with porcine bioprosthetic cardiac valves. , 1986, The Journal of thoracic and cardiovascular surgery.

[18]  C. Duran,et al.  Degeneration in porcine bioprosthetic cardiac valves: incidence of primary tissue failures among 938 bioprostheses at risk. , 1984, The American journal of cardiology.

[19]  A. Mazzucco,et al.  Isolated mitral valve replacement with the Hancock bioprosthesis: a 13-year appraisal. , 1984, The Annals of thoracic surgery.

[20]  G Thiene,et al.  Results of reoperation for primary tissue failure of porcine bioprostheses. , 1985, The Journal of thoracic and cardiovascular surgery.

[21]  E. Peterson,et al.  The porcine bioprosthetic valve. Twelve years later. , 1985, The Journal of thoracic and cardiovascular surgery.

[22]  W. Jamieson,et al.  The Carpentier-Edwards supraannular porcine bioprosthesis. A new generation tissue valve with excellent intermediate clinical performance. , 1988, The Journal of thoracic and cardiovascular surgery.

[23]  W. Baumgartner,et al.  The durability of porcine xenograft valves and conduits in children. , 1982, Circulation.